Oxaliplatin, 5-FU and folinic acid (OFFA) as II-line chemotherapy in advanced colorectal cancer

被引：2
|
作者：
Tassinari, D [1 ]
Panzini, I [1 ]
Pasquini, E [1 ]
Desiderio, F [1 ]
Drudi, G [1 ]
Fattori, PP [1 ]
Gianni, L [1 ]
Oliveno, G [1 ]
Tononi, A [1 ]
Ravaioli, A [1 ]
机构：
[1] City Hosp, Dept Oncol, Rimini, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80690-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
257
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] First line chemotherapy with bolus 5-FU and folinic acid plus oxaliplatin in advanced colorectal cancer: Preliminary data of a phase II trial.
    Ravaioli, A
    Amadori, D
    Cruciani, G
    Frassineti, L
    Marangolo, M
    Panzini, I
    Pasquini, E
    Rossi, A
    Turci, D
    Tassinari, D
    ANNALS OF ONCOLOGY, 2000, 11 : 50 - 50
  • [2] FLOX regimen (5-FU, folinic acid, oxaliplatin) and FLIRI regimen (5-FU, folinic acid, irinotecan) as first-line treatment in metastatic and locally advanced gastric cancer: A randomized phase II study.
    Glenjen, Nils
    Hammerling, Katrin
    Hatlevoll, Ingunn
    Smaland, Rune
    Hauge, Petra Weber
    Eide, Geir Egil
    Sorbye, Halfdan
    Dahl, Olav
    Frykholm, Gunilla
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Hepatic Arterial Infusion with Oxaliplatin and 5-FU/Folinic Acid for Advanced Biliary Tract Cancer: A Phase II Study
    Sinn, M.
    Nicolaou, A.
    Gebauer, B.
    Podrabsky, P.
    Seehofer, D.
    Ricke, J.
    Doerken, B.
    Riess, H.
    Hildebrandt, B.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (08) : 2399 - 2405
  • [4] Hepatic Arterial Infusion with Oxaliplatin and 5-FU/Folinic Acid for Advanced Biliary Tract Cancer: A Phase II Study
    M. Sinn
    A. Nicolaou
    B. Gebauer
    P. Podrabsky
    D. Seehofer
    J. Ricke
    B. Dörken
    H. Riess
    B. Hildebrandt
    Digestive Diseases and Sciences, 2013, 58 : 2399 - 2405
  • [5] 5-fluorouracil (5-FU),folinic acid (FA) and oxaliplatin (FUFOX) as second chemotherapy in patients with metastatic colorectal cancer (MCRC)
    Andric, Z.
    Murtezani, Z.
    Kovcin, V
    Gutovic, J.
    Kostic, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 66 - 67
  • [6] Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer
    Choi, I
    Oh, D.
    Kim, B.
    Lee, K.
    Kim, J.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 51 - 51
  • [7] WEEKLY REGIMEN OF 5-FU VS 5-FU PLUS INTERMEDIATE DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    MARTONI, A
    CRICCA, A
    GUARALDI, M
    COVIZZI, M
    FARRIS, A
    PANNUTI, F
    ANTICANCER RESEARCH, 1992, 12 (03) : 607 - 612
  • [8] Oxaliplatin with 5-FU or as a single agent in advanced/metastatic colorectal cancer
    Mitchell, EP
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 30 - 32
  • [9] Oxaliplatin/5-FU chemotherapy without leucovorin in metastatic colorectal cancer.
    Shim, BY
    Cho, HJ
    Yang, JM
    Kim, HJ
    Kim, JK
    Kim, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 302S - 302S
  • [10] FIRST LINE CHEMOTHERAPY (FLC) USING OXALIPLATIN, 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) (FOLFOX-4) COMBINED WITH BEVACIZUMAB IN METASTATIC COLORECTAL CANCER (MCRC)
    Gluzman, A.
    Fridman, J.
    Lazarev, I
    Man, S.
    Walfish, S.
    Ariad, S.
    Lavrenkov, K.
    ANNALS OF ONCOLOGY, 2009, 20 : 66 - 66
12345